1.
Ozodbekova U. GLP-1-Based Therapies in Type 2 Diabetes and Obesity: Current Evidence, Cardiorenal Benefits, Safety and Future Directions. BCR [Internet]. 2026 Nov. 13 [cited 2026 Nov. 16];2(4):118-23. Available from: https://bulconre.com/index.php/mult/article/view/54